National Business

TORONTO — Brookfield Asset Management Inc. has offered US$5.9 billion to buy the remaining stake in Brookfield Property Partners LP that it does not already own. The asset management company is offering US$16.50 per unit.

Tim Hortons is hoping the third time's a charm as it rolls out its latest iteration of a dark roast coffee this week, a key part of the chain’s back-to-basics plan that will focus on its core offerings of coffee, doughnuts and breakfast in 2021.

WASHINGTON — Spending on U.S. construction projects increased 0.9% in November as strength in home building offset weakness in other parts of the construction industry. The November gain followed a bigger 1.

MONTREAL — Investment manager Fiera Capital Corp. says it is selling a pair of operations in the United States in two separate deals.

NEW DELHI — India authorized two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second-most populous country.

TORONTO — Canadian companies may have spent the past year laying off staff and dealing with temporary closures stemming from the COVID-19 pandemic, but that isn't stopping many from rewarding workers this holiday season.

TORONTO — Five things to watch for in the Canadian business world in the coming week: December auto sales DesRosiers Automotive Consultants Inc. is scheduled to release its December auto sales data for Canada on Tuesday.

SYDNEY, Australia — More Australian states and territories are reimposing travel restrictions to prevent the spreading of the coronavirus from new outbreaks in New South Wales and Victoria states.

NEW DELHI — India tested its COVID-19 vaccine delivery system with a nationwide trial on Saturday, as it prepares to roll out an inoculation program to stem the coronavirus pandemic.

WASHINGTON — The Senate wrapped up a rare New Year's Day session with Republicans rejecting President Donald Trump's demand for $2,000 COVID-19 aid checks and overriding his veto of a sweeping defence bill, an unusual one-two rebuke at the end of a c